PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Asia Pacific

FDA Green-Lights Two Therapies, While Late-Stage Successes Set Stage for Potential Approvals

The U.S. Food and Drug Administration (FDA) has been busy approving new treatments for various diseases. Two days into the new week and the regulatory agency has gre...
Continue Reading →
Asia Pacific

Takeda’s Entyvio beats AbbVie’s Humira in head-to-head UC study

Takeda's Entyvio outperformed AbbVie's Humira as an ulcerative colitis therapy, according a topline readout of a Phase 3b study by the Japanese pharma.The ...
Continue Reading →
news

New drug may stop sepsis from reaching major organs

Researchers discover a drug that has the potential to stop sepsis before the condition reaches major organs and becomes fatal. A new preclinical trial of a sep...
Continue Reading →
news

New brain stimulation therapy is effective against depression

A new clinical trial has tested the ability of a little-studied, noninvasive brain stimulation technique to treat the symptoms of major depression. The results, so ...
Continue Reading →
news

Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors

Novo Nordisk announced publication of results from the SUSTAIN 9 Phase 3b trial in The Lancet Diabetes & Endocrinology. The objective of this 30 week trial was t...
Continue Reading →
Europe

Envigo launches PATHWAY, an optimized safety assessment solution to enable first-in-human clinical trials

11 March 2019, East Millstone, N.J. – Envigo, a leading provider of non-clinical contract research services and research models, announced today the launch of PATHWA...
Continue Reading →
Europe

ERYTECH Presents Findings at European Red Cell Research Society Meeting

LYON, France and CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical compa...
Continue Reading →
Europe

Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease

Product is the result of a partnership with Integrated DNA Technologies, and provides clinical-stage clients with a critical raw material. FARGO, ND (March 12, 201...
Continue Reading →
Europe

ECCO 2019: Entyvio set to be most dominant drug in the UC landscape following VARSITY trial, says GlobalData

The results of the VARSITY trial, a head-to-head Phase IIIb double-blind, double-dummy, multicentre, active controlled study, that evaluates the efficacy and safety ...
Continue Reading →
Europe

Successful Phase 2 Clinical Trial Results with Novel Influenza Vaccine Validate SGS’s H3N2 Challenge Agent (A/Belgium)

Antwerp, Belgium March 12, 2019: SGS, a leading life-sciences, clinical and bioanalytical contract solutions provider, today welcomed the preliminary data from ...
Continue Reading →
Quotient